Euticals (now part of Curia)
Is this your company? Claim this profile
Drug Product
Company Overview
About
Euticals (now part of Curia) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:France
Founded:2005
Employees:589
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Global
International Regulatory
EU GMP Certificates
1
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval 6I1TOE
PMDA · #APR-BP84WUW3 · 2019-11-01
Drug Approval V9XR0G
FDA · #APR-JBMW3J50 · 2020-04-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
WHO GMP
World Health Organization
Cert #: CERT-5HVHHDLX
Issued: 2020-11-27
Expires: 2025-11-01
Health Canada GMP
Health Canada
Cert #: CERT-EM5KRNRG
Issued: 2020-05-27
Expires: 2025-05-03
Loading CDMO intelligence...
Key facts about Euticals (now part of Curia)
- Euticals (now part of Curia) is headquartered in France.
- Euticals (now part of Curia) was founded in 2005.
- Euticals (now part of Curia) has 589 employees.
- Euticals (now part of Curia)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Euticals (now part of Curia)
Directory pages this company appears in, each with the full list of matching manufacturers.